ישראל - עברית - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 500 iu/vial - powder for solution for injection - coagulation factor vii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

ישראל - עברית - Ministry of Health

remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - אבקה להכנת תמיסה לזריקה - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations - combinations - vitamin supplementation in patients receiving parenteral nutrition. only for adults and children over 11 years of age.

ישראל - עברית - Ministry of Health

remedix care ltd - glycine; l- alanine; l- aspartic acid; l- cysteine; l- glutamic acid; l- isoleucine; l- leucine; l- lysine; l- methionine; l- ornithine hydrochloride; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; taurine - תמיסה לאינפוזיה - l- valine 0.76 g / 100 ml; l- tyrosine 0.045 g / 100 ml; l- tryptophan 0.2 g / 100 ml; l- threonine 0.37 g / 100 ml; taurine 0.06 g / 100 ml; l- serine 0.4 g / 100 ml; l- proline 0.3 g / 100 ml; l- phenylalanine 0.42 g / 100 ml; l- ornithine hydrochloride 0.318 g / 100 ml; l- methionine 0.24 g / 100 ml; l- lysine 1.1 g / 100 ml; l- leucine 1.0 g / 100 ml; l- isoleucine 0.67 g / 100 ml; l-histidine 0.38 g / 100 ml; glycine 0.4 g / 100 ml; l- glutamic acid 1.0 g / 100 ml; l- cysteine 0.189 g / 100 ml; l- aspartic acid 0.6 g / 100 ml; l-arginine 0.84 g / 100 ml; l- alanine 0.8 g / 100 ml - lysine - lysine - primene 10 % is indicated in 1) children and infants 2) neonates at term or premature of normal or low birth weight when oral or enteral nutrition is impossible insufficient or contraindicated.

ישראל - עברית - Ministry of Health

takeda israel ltd - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - ivig can be used in all age ranges, unless otherwise specified below.replacement therapy in:primary immunodeficiency syndromes with impaired antibody production.hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.children and adolescents (age 0-18) with congenital aids and recurrent bacterial infections.hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (hsct).immunomodulationprimary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.guillain barr? syndrome.kawasaki disease.

ישראל - עברית - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 500 mg/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

ישראל - עברית - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 1 g/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

ישראל - עברית - Ministry of Health

megapharm ltd - bleomycin sulfate - אבקה להכנת תמיסה לזריקה - bleomycin sulfate 15000 iu/vial - bleomycin - bleomycin - bleomycin is useful in the management of the following neoplasms: squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. well differentiated tumors usually respond better than anaplastic ones.hodgkin's disease and other malignant lymphomas, including mycosis fungoides. testicular carcinoma (seminoma and no seminoma) .malignant effusions of serous cavities (intrapleural and intraperitoneal).secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. local treatment of refractory warts. bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - glycine 5.67 g / 1000 ml; l- alanine 11.39 g / 1000 ml; l-histidine 2.64 g / 1000 ml; l-arginine 6.33 g / 1000 ml; l- methionine 2.20 g / 1000 ml; l- lysine as hydrochloride 3.19 g / 1000 ml; l- isoleucine 3.30 g / 1000 ml; l- threonine 2.31 g / 1000 ml; l- tryptophan 0.99 g / 1000 ml; l- proline 3.74 g / 1000 ml; l- phenylalanine 3.08 g / 1000 ml; l- valine 3.19 g / 1000 ml; l- tyrosine 0.22 g / 1000 ml; l- leucine 4.02 g / 1000 ml; l- serine 2.75 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 2.45 g / 1000 ml; refined soya-bean oil 100 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 200 g / 1000 ml; potassium chloride 2.98 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - refined soya-bean oil 200.00 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 250.00 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.06 g / 1000 ml; l- tyrosine 0.28 g / 1000 ml; l- tryptophan 1.26 g / 1000 ml; l- threonine 2.94 g / 1000 ml; l- serine 3.50 g / 1000 ml; l- proline 4.76 g / 1000 ml; l- phenylalanine 3.92 g / 1000 ml; l- methionine 2.80 g / 1000 ml; l- lysine as hydrochloride 4.06 g / 1000 ml; l- leucine 5.11 g / 1000 ml; l- isoleucine 4.20 g / 1000 ml; l-histidine 3.36 g / 1000 ml; glycine 7.21 g / 1000 ml; l-arginine 8.05 g / 1000 ml; l- alanine 14.49 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined olive oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - l- alanine 17.60 g / 1000 ml; refined olive oil 200 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 300 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.93 g / 1000 ml; l- tyrosine 0.34 g / 1000 ml; l- tryptophan 1.53 g / 1000 ml; l- threonine 3.57 g / 1000 ml; l- serine 4.25 g / 1000 ml; l- proline 5.78 g / 1000 ml; l- phenylalanine 4.76 g / 1000 ml; l- methionine 3.40 g / 1000 ml; l- lysine as hydrochloride 4.93 g / 1000 ml; l- leucine 6.21 g / 1000 ml; l- isoleucine 5.10 g / 1000 ml; l-histidine 4.08 g / 1000 ml; glycine 8.76 g / 1000 ml; l-arginine 9.78 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.